Nov 22, 2010 Funding decisions for B.C.'s drug formulary to be based on industry marketing instead of independent drug assessment Read more … [Read more...]
BC New Drug Review ‘Jeopardizing Lives’
Province went from best to worst in evaluating pharmaceuticals, charges Canadian Health Coalition official Andrew MacLeod TheTyee.ca 24 November 2010 British Columbia has corrupted its drug review process, making changes that will cost lives and money. Read more … [Read more...]
Drug watchdog agency curtailed; New program skews process to favour pharmaceutical firms, advocacy group says
Vancouver Sun Wed Nov 24 2010 - Section A2 (Westcoast News) Margaret Munro B.C.'s internationally acclaimed drug watchdog is being defanged in favour of a new system that gives pharmaceutical companies advanced inside information on drug coverage decisions. Read more … [Read more...]
Province’s drug watchdog program losing its bite
Times Colonist (Victoria) Margaret Munro Wed Nov 24 2010. Page: B1 / Front (Section: Business) B.C.'s internationally acclaimed drug watchdog is being defanged in favour of a new system that gives pharmaceutical companies advance inside information on drug coverage decisions. Read more … [Read more...]
B.C. revamping vaunted drug watchdog program
Postmedia News Regional News - British Columbia Margaret Munro Wed Nov 24 2010 VANCOUVER - B.C.'s internationally acclaimed drug watchdog is being defanged in favour of a new system that gives pharmaceutical companies advanced inside information on drug coverage decisions. Read More … [Read more...]
Critics decry change in drug-approval process
Government abolishing drug review body, allowing drug makers four separate chances to pitch their products. The Globe and Mail Rod Mickleburgh Wed Nov 24 2010, Page: S1 (Section: British Columbia News) VANCOUVER -- British Columbia's widely applauded independent drug- approval process is being dramatically altered to make room for more input by pharmaceutical companies, a change decried by … [Read more...]
To Do No Harm: Regulation of pharmaceutical promotion and protection of patient health
November 29 - November 29, 2010 To Do No Harm: Regulation of pharmaceutical promotion and protection of patient health is a full-day international symposium to be held on Monday, November 29, 2010 in Toronto, Ontario. The event is hosted by the Pharmaceutical Policy Research Collaboration together with researchers on an international study on Pharmaceutical Sales Representative and Patient … [Read more...]
Cochrane Canada 9th Annual Symposium
Early Exposure to Cochrane: accessible, credible & practical We invite researchers, academics, methodologists, physicians, nurses, healthcare professionals, policy-makers, consumers, students and anyone involved in the health field to join us at the 9th Annual Cochrane Canada Symposium. The Symposium takes place 16-17 February 2011 at the Fairmont Pacific Rim in Vancouver, … [Read more...]
Is disease mongering selling fear and medications?
The Georgia Straight interviews Ray Moynihan about his new book "Sex, Lies, And Pharmaceuticals: How Drug Companies Plan To Profit From Female Sexual Dysfunction" Read More … [Read more...]
Rosiglitazone Update
Rosiglitazone (Avandia) suspended from the Saudi Arabian market The Saudi Food and Drug Authority (SFDA) announced on March 14, 2010 that the marketing authorization for rosiglitazone (Avandia) and all combination products containing rosiglitazone was suspended for safety reasons. The suspension is for a period of six months during which time no rosiglitazone or rosiglitazone containing … [Read more...]
